Press Releases from DelveInsight (457 total)
Narcolepsy Market Insight, Epidemiology, and Market Forecast - 2034: Innovation …
Narcolepsy, a chronic neurological disorder affecting the brain's ability to regulate sleep-wake cycles, significantly impairs patients' daily functioning and quality of life. Characterized by excessive…
Danon Disease Market Outlook 2034: Gene Therapies and Precision Medicine Drive F …
Danon Disease, an ultra-rare, X-linked dominant genetic disorder caused by mutations in the LAMP2 gene, leads to impaired autophagy and lysosomal dysfunction, predominantly affecting the…
Wolman Disease Market Forecast 2034: Advancing Therapeutics in an Ultra-Rare Lan …
Wolman Disease, a severe and ultra-rare lysosomal storage disorder caused by mutations in the LIPA gene, leads to a near-complete deficiency of lysosomal acid lipase…
AL Amyloidosis Market Outlook 2034: Rising Awareness and Emerging Therapies Set …
AL (Light Chain) Amyloidosis, a rare and life-threatening disorder characterized by the abnormal deposition of misfolded light chain proteins in vital organs, continues to pose…
Mantle Cell Lymphoma Treatment Market Size in 7MM is expected to grow at a decen …
DelveInsight's "Mantle Cell Lymphoma Treatment Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Mantle cell lymphoma, historical and…
T-Cell Prolymphocytic Leukemia Pipeline: 5+ Companies Advancing Novel Therapeuti …
The therapeutic landscape for T-Cell Prolymphocytic Leukemia (T-PLL), a rare and aggressive form of mature T-cell leukemia, is witnessing growing research interest as biotech and…
Propionic Acidemia Pipeline Insights 2025: Emerging Therapies and Future Treatme …
The therapeutic landscape for Propionic Acidemia (PA), a rare inherited metabolic disorder caused by deficiency of the propionyl-CoA carboxylase enzyme, is advancing steadily with multiple…
Primary Mitochondrial Myopathies (PMM) Pipeline: Advancing Therapies Targeting M …
The therapeutic landscape for Primary Mitochondrial Myopathies (PMM) is rapidly progressing, driven by the urgent need to address the complex and heterogeneous nature of these…
Minimal Change Disease Pipeline: Advancing Targeted Therapies for Improved Patie …
The therapeutic landscape for Minimal Change Disease (MCD) is witnessing promising advancements as researchers and biopharmaceutical companies focus on developing innovative treatments to address this…
Nosocomial Pneumonia Pipeline: Key Advances and Emerging Therapies Shaping Treat …
The treatment landscape for Nosocomial Pneumonia continues to advance, driven by the urgent need to combat antibiotic resistance and improve patient outcomes in hospital settings.…
Cardiogenic Shock Pipeline: Advancing Therapeutics and Innovative Interventions …
Cardiogenic Shock (CS), a life-threatening condition marked by the heart's inability to pump sufficient blood to meet the body's needs, remains a critical unmet need…
Central Serous Chorioretinopathy Pipeline: Emerging Therapies and Future Outlook …
Central Serous Chorioretinopathy (CSCR) is a retinal disorder with limited treatment options and significant unmet needs. The CSCR pipeline is evolving with innovative therapies targeting…
Centronuclear Myopathy Pipeline: 5+ Companies Advancing Therapies for Rare Neuro …
The treatment landscape for Centronuclear Myopathy (CNM), a group of rare inherited neuromuscular disorders characterized by muscle weakness and abnormal centralization of nuclei in muscle…
Chronic Hepatitis C Virus Infection Pipeline: 8+ Companies Advancing Therapies f …
The therapeutic landscape for Chronic Hepatitis C Virus (HCV) infection continues to evolve, with a focus on advancing antiviral regimens and enhancing treatment outcomes. Despite…
Chronic Hepatitis B Virus Pipeline: 50+ Companies Driving Next-Generation Therap …
The therapeutic landscape for Chronic Hepatitis B Virus (HBV) infection, a globally prevalent and potentially life-threatening liver disease, is rapidly evolving with innovative treatment candidates…
Laband Syndrome Market Outlook Poised for Scientific Attention by 2034 | DelveIn …
Laband Syndrome, also known as Zimmermann-Laband Syndrome, is an ultra-rare genetic disorder marked by gingival fibromatosis, distinctive facial features, joint hypermobility, and nail and bone…
Palmar Hyperhidrosis Market Set for Strong Growth by 2034 - DelveInsight | Key P …
Palmar Hyperhidrosis, a chronic dermatological condition characterized by excessive sweating of the palms, continues to impact quality of life and psychological well-being for millions of…
Vaso-Occlusive Crisis Market Set for Significant Growth by 2034 - DelveInsight | …
Vaso-Occlusive Crisis (VOC), a severe and painful complication of sickle cell disease, poses a substantial burden on patients and healthcare systems globally. The VOC market…
Leigh Syndrome Market Poised for Robust Growth by 2034: Unlocking New Therapies …
Leigh Syndrome, a rare and severe mitochondrial disorder predominantly affecting infants and young children, presents significant clinical challenges due to its complex neurological manifestations and…
Thymidine Kinase 2 Deficiency Market Set to Witness Significant Growth by 2034 | …
Thymidine Kinase 2 (TK2) Deficiency, a rare and progressive mitochondrial DNA depletion syndrome, presents considerable challenges in diagnosis, clinical management, and long-term outcomes due to…
BRAF-mutant Non-Small Cell Lung Cancer Pipeline: 10+ Companies Advancing Targete …
The treatment landscape for BRAF-mutant Non-Small Cell Lung Cancer (BRAF+ NSCLC), a molecular subtype of NSCLC driven by mutations in the BRAF gene, most commonly…
ALK-positive Non-Small Cell Lung Cancer Pipeline: Companies Advancing Targeted T …
The therapeutic landscape for ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC), a genetically defined subset of lung cancer driven by ALK gene rearrangements, is undergoing…
Bruton's Tyrosine Kinase (BTK) Inhibitors Pipeline Set to Transform Oncology and …
The therapeutic landscape for Bruton's Tyrosine Kinase (BTK) inhibitors is undergoing a significant transformation, driven by the urgent need for targeted therapies in oncology and…
Fabry Disease Pipeline Overview: Over 18 Companies Driving Innovation in Targete …
The therapeutic landscape for Fabry disease, a rare genetic lysosomal storage disorder caused by deficient alpha-galactosidase A enzyme activity, is undergoing significant transformation. Biopharmaceutical developers…
Diabetes Pipeline: 200+ Companies Driving Innovation in Glucose Control, Disease …
The treatment landscape for diabetes is undergoing a significant transformation as the global burden of the disease continues to rise. With over 200 companies advancing…
Neisseria Meningitidis Meningitis Pipeline: Advancing Preventive and Therapeutic …
The therapeutic and preventive landscape for Neisseria Meningitidis Meningitis, a rapidly progressing and life-threatening bacterial infection of the membranes surrounding the brain and spinal cord,…
Neurofibromatosis Type 1 Pipeline: Emerging Targeted Therapies and Gene-Based Ap …
The treatment landscape for Neurofibromatosis Type 1 (NF1), a rare genetic disorder characterized by nerve sheath tumors, skin changes, and other systemic complications, is undergoing…
Lung Adenocarcinoma Pipeline: 25+ Companies Advancing Targeted Therapies and Imm …
The treatment landscape for lung adenocarcinoma, a leading form of non-small cell lung cancer (NSCLC), is undergoing a significant transformation. Once limited to traditional chemotherapy…
Liver Fibrosis Pipeline: 50+ Companies Advancing Antifibrotic Therapies and Dise …
The therapeutic landscape for liver fibrosis, a pathological scarring process resulting from chronic liver injury, is rapidly evolving, as biopharmaceutical innovators shift their focus from…
Essential Tremor Pipeline: Advancing Neuromodulation and Targeted Therapies to T …
The treatment landscape for Essential Tremor (ET), a prevalent neurological movement disorder characterized by involuntary rhythmic shaking, is undergoing a significant evolution. Historically managed with…
Diabetic Gastroparesis Pipeline: Emerging Therapies and Innovations in Gastroint …
The treatment landscape for Diabetic Gastroparesis (DG), a debilitating condition characterized by delayed gastric emptying in diabetic patients, is witnessing significant advancements as current therapeutic…
Cirrhosis Pipeline: Novel Antifibrotic Therapies and Regenerative Approaches Red …
The treatment landscape for cirrhosis, a progressive liver condition marked by fibrosis and compromised liver function, is witnessing a transformative shift as biopharmaceutical companies advance…
Cluster Headache Syndrome Pipeline: Advancing Targeted Therapies and Breakthroug …
The treatment landscape for Cluster Headache Syndrome (CHS), a debilitating and highly painful neurological condition, is evolving as new therapies are being developed to address…
Constipation Pipeline Insight, 2025: Key Players Shaping the Future, including A …
The treatment landscape for constipation, a prevalent gastrointestinal disorder, is undergoing significant advancements as new therapies aim to address the limitations of traditional treatments. As…
Critical Limb Ischemia Pipeline: Advancing Regenerative Therapies and Novel Inte …
The treatment landscape for Critical Limb Ischemia (CLI), the most severe form of peripheral arterial disease, is evolving rapidly as the limitations of conventional revascularization…
Chemotherapy-Induced Nausea and Vomiting Pipeline: Emerging Therapies and Key Co …
The therapeutic landscape for Chemotherapy-Induced Nausea and Vomiting (CINV), one of the most distressing side effects of cancer treatment, is evolving rapidly with a growing…
Chikungunya Pipeline Insight 2025: 10+ Advancing Therapies and Key Companies in …
The therapeutic landscape for Chikungunya, a viral disease transmitted by mosquitoes that causes severe joint pain, fever, and rash, is rapidly evolving, fueled by advancements…
Chemotherapy-Induced Anemia Pipeline: Pioneering Treatments and Leading Companie …
The landscape for treating chemotherapy-induced anemia is evolving rapidly, driven by the development of novel therapies aimed at addressing the unmet needs of patients suffering…
Chondrosarcoma Pipeline: Advancing Therapeutics and 15+ Leading Companies Shapin …
The therapeutic landscape for Chondrosarcoma, a rare and aggressive bone cancer, is rapidly evolving, driven by advances in molecular biology, targeted therapies, and a deeper…
Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying…
Inter Alpha Inhibitor Treatment Market Size in 7MM is expected to grow at a dece …
DelveInsight's "Inter Alpha Inhibitor Proteins Market Insights, Epidemiology, and Market Forecast- 2032" report delivers an in-depth understanding of the Inter Alpha Inhibitor Proteins, historical and…
Cancer Cachexia Pipeline: Emerging Therapies Set to Transform the Cancer Cachexi …
The treatment landscape for Cancer Cachexia, a multifactorial syndrome characterized by progressive weight loss, muscle wasting, and fatigue in cancer patients, is undergoing significant evolution,…
Biliary Tumor Pipeline Insight 2025: 50+ Companies Advancing Groundbreaking Ther …
The treatment landscape for biliary tumors, including cholangiocarcinoma and gallbladder cancer, is witnessing significant innovation, propelled by an expanding pipeline of targeted therapies and immuno-oncology…
Bacteremia Pipeline: Emerging Therapies Set to Transform Bacteremia Treatment La …
The bacteremia treatment landscape is rapidly evolving, driven by innovative therapies from leading pharma and biotech companies targeting the complex pathogenesis of bacterial infections. Companies…
Ataxia Pipeline: Advancing Therapeutics and 32+ Leading Companies Shaping the At …
The therapeutic landscape for Ataxia, a group of rare neurological disorders characterized by impaired coordination and balance, is witnessing significant momentum, driven by advances in…
Aspergillosis Pipeline: 20+ Promising Therapies Poised to Redefine the Aspergill …
The treatment paradigm for Aspergillosis, a serious fungal infection primarily affecting immunocompromised individuals, is rapidly evolving with a robust pipeline of antifungal agents under clinical…
Primary Myelofibrosis Pipeline: 55+ Companies Driving Innovations in Treatment a …
The treatment landscape for Primary Myelofibrosis (PMF), a rare and chronic bone marrow disorder, is advancing significantly, fueled by innovative therapies from leading pharmaceutical and…
Primary Open Angle Glaucoma Clinical Trial Pipeline: Emerging Therapies Shaping …
The treatment landscape for Primary Open Angle Glaucoma (POAG), a leading cause of blindness worldwide, is undergoing significant transformation, driven by cutting-edge therapies from top…
Progressive Familial Intrahepatic Cholestasis Pipeline: Promising Therapies Shap …
The treatment landscape for Progressive Familial Intrahepatic Cholestasis (PFIC), a rare and progressive liver disorder, is evolving rapidly, driven by innovative therapies from leading pharmaceutical…
Prurigo Nodularis Pipeline: Emerging Therapies Set to Reshape the Prurigo Nodula …
The treatment landscape of Prurigo Nodularis (PN), a chronic, intensely pruritic skin disorder, is undergoing a dynamic transformation, fueled by a growing pipeline of novel…
